Skip to main content
. 2022 May 1;26(5):373–381. doi: 10.5152/AnatolJCardiol.2021.901

Figure 4.

Figure 4.

Mir-615-3p inactivates the P13K/Akt pathway by inhibiting MEF2A. (A-B) H/R-stimulated HCMs were pretreated with NC mimics, miR-615-3p mimics, or cotreated with miR-615-3p mimics+MEF2A overexpression vector, and the protein levels of phosphorylated PI3K, Akt and total PI3K, Akt proteins were measured by Western blot analyses. *P < .01, ***P < .001. HCMs, human cardiomyocytes